898 abstracts found.



Results filter



Models for delivery of follow-up care – what does the evidence tell us thus far?

Year:

Session type:

Jon Emery1,

1University of Melbourne, Melbourne, Australia




Optimising care beyond breast cancer – perspectives from the front line

Year:

Session type:

Alastair M Thompson1, Maggie Wilcox2,
1University of Texas MD Anderson Cancer Center, Houston, USA,2Independent Cancer Patients' Voice, London, UK



The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site

Year:

Session type:

Richard Vile1,
1Mayo Clinic, Rochester, USA



Making sense of intratumour heterogeneity: evidence of a ‘Big Bang’ tumour expansion

Year:

Session type:

Andrea Sottoriva1,
1The Institute of Cancer Research, London, UK



Introduction: Optimising care for those living with and beyond cancer – where does primary care fit in?

Year:

Session type:

Eila Watson1,
1Oxford Brookes University, UK, Oxford, UK



Co-targeting angiogenesis and immunosuppressive cell networks to improve anti-cancer therapy

Year:

Session type:

Michele De Palma1,
The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland (1)



Unravelling the complexity of lung cancer evolution

Year:

Session type:

Nicholas McGranahan1,
1CR-UK London Research Institute, London, UK



Primary care views on optimising care for those living with and beyond cancer: findings from a systematic review and GP survey

Year:

Session type:

Fiona Walter1,
1University of Cambridge, Cambridge, UK



Neutrophil-derived signals promote initiation abilities of cancer stem cells during metastasis

Year:

Session type:

Ilaria Malanchi1,
1Cancer Research UK, London, UK



Computational dissection of intratumour genetic heterogeneity and applications to the study of cancer treatment, evolution and metastasis

Year:

Session type:

Scott Carter1,2,
1Broad Institute of MIT-Harvard, Cambridge, MA, USA,2Dana-Farber Cancer Institute, Boston, MA, USA,3Massachusetts General Hospital, Boston, MA, USA

Page 1 of 901...25...Last »